Literature DB >> 19713850

Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis.

Andrea Henriques-Pons1, Kanneboyina Nagaraju.   

Abstract

PURPOSE OF REVIEW: Recent literature in inflammatory myopathies suggests that both immune (cell-mediated and humoral) and nonimmune [endoplasmic reticulum (ER) stress and autophagy] mechanisms play a role in muscle fiber damage and dysfunction. This review describes these findings and discusses their relevance to disease pathogenesis and therapy. RECENT
FINDINGS: Recent studies highlight the role of ER stress response, especially the roles of hexose-6-phosphate dehydrogenase and ER-anchored RING finger E3 ligase in the activation of unfolded protein response and the formation of vacuoles and inclusions in myopathies. Several studies investigated the link between inflammation and the beta-amyloid-associated muscle fiber degeneration and loss of muscle function. Likewise, the roles of ER stress and autophagy in skeletal muscle damage have been explored in multiple muscle diseases.
SUMMARY: Current data indicate that the ER stress, nuclear factor-kappaB pathway and autophagy are active in the skeletal muscle of myositis patients, and the proinflammatory nuclear factor-kappaB pathway connects the immune and nonimmune pathways of muscle damage. The relative contributions of each of these pathways to muscle fiber damage are currently unclear. Therefore, further defining the role of these pathways in disease pathogenesis should help to design effective therapeutic agents for these diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19713850      PMCID: PMC2877394          DOI: 10.1097/BOR.0b013e3283319265

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  43 in total

Review 1.  Role of major histocompatibility complex class I molecules in autoimmune myositis.

Authors:  Kanneboyina Nagaraju
Journal:  Curr Opin Rheumatol       Date:  2005-11       Impact factor: 5.006

2.  Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy.

Authors:  Sophie Pattingre; Amina Tassa; Xueping Qu; Rita Garuti; Xiao Huan Liang; Noboru Mizushima; Milton Packer; Michael D Schneider; Beth Levine
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction.

Authors:  Kanneboyina Nagaraju; Livia Casciola-Rosen; Ingrid Lundberg; Rashmi Rawat; Shawna Cutting; Rachana Thapliyal; Jason Chang; Sunita Dwivedi; Megan Mitsak; Yi-Wen Chen; Paul Plotz; Antony Rosen; Eric Hoffman; Nina Raben
Journal:  Arthritis Rheum       Date:  2005-06

4.  Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.

Authors:  Y Nawata; K Kurasawa; K Takabayashi; S Miike; N Watanabe; M Hiraguri; Y Kita; M Kawai; Y Saito; I Iwamoto
Journal:  J Rheumatol       Date:  1999-07       Impact factor: 4.666

Review 5.  Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders.

Authors:  P H Plotz; M Dalakas; R L Leff; L A Love; F W Miller; M E Cronin
Journal:  Ann Intern Med       Date:  1989-07-15       Impact factor: 25.391

6.  Expression of the CD85j (leukocyte Ig-like receptor 1, Ig-like transcript 2) receptor for class I major histocompatibility complex molecules in idiopathic inflammatory myopathies.

Authors:  Nicolas Schleinitz; Celine Cognet; Sophie Guia; Fanny Laugier-Anfossi; Myriam Baratin; Jean Pouget; Jean-Francois Pelissier; Jean-Robert Harle; Eric Vivier; Dominique Figarella-Branger
Journal:  Arthritis Rheum       Date:  2008-10

7.  A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.

Authors:  E M Adams; F Pucino; C Yarboro; J E Hicks; B Thornton; C McGarvey; B C Sonies; M L Bartlett; M L Villalba; T Fleisher; P H Plotz
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

8.  Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls.

Authors:  I Lundberg; J M Brengman; A G Engel
Journal:  J Neuroimmunol       Date:  1995-12       Impact factor: 3.478

Review 9.  Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.

Authors:  Claire Henchcliffe; M Flint Beal
Journal:  Nat Clin Pract Neurol       Date:  2008-11

10.  Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta.

Authors:  Masashi Kitazawa; Dan N Trinh; Frank M LaFerla
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

View more
  16 in total

1.  Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target.

Authors:  Sree Rayavarapu; William Coley; Jack H Van der Meulen; Erdinc Cakir; Kathyayini Tappeta; Travis B Kinder; Blythe C Dillingham; Kristy J Brown; Yetrib Hathout; Kanneboyina Nagaraju
Journal:  Arthritis Rheum       Date:  2013-12

2.  Role of innate immunity in a murine model of histidyl-transfer RNA synthetase (Jo-1)-mediated myositis.

Authors:  Makoto Soejima; Eun Ha Kang; Xinyan Gu; Yasuhiro Katsumata; Paula R Clemens; Dana P Ascherman
Journal:  Arthritis Rheum       Date:  2011-02

Review 3.  Secretory pathway stress responses as possible mechanisms of disease involving Golgi Ca2+ pump dysfunction.

Authors:  Gary E Shull; Marian L Miller; Vikram Prasad
Journal:  Biofactors       Date:  2011-06-14       Impact factor: 6.113

4.  The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damage.

Authors:  Heather M Alger; Nina Raben; Emidio Pistilli; Dwight L Francia; Rashmi Rawat; Derese Getnet; Svetlana Ghimbovschi; Yi-Wen Chen; Ingrid E Lundberg; Kanneboyina Nagaraju
Journal:  Arthritis Rheum       Date:  2011-11

Review 5.  The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.

Authors:  Angela Ceribelli; Maria De Santis; Natasa Isailovic; M Eric Gershwin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 6.  Cutting edge issues in polymyositis.

Authors:  Anna Ghirardello; Sandra Zampieri; Elena Tarricone; Luca Iaccarino; Luisa Gorza; Andrea Doria
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 7.  Pathogenesis, classification and treatment of inflammatory myopathies.

Authors:  Mei Zong; Ingrid E Lundberg
Journal:  Nat Rev Rheumatol       Date:  2011-04-05       Impact factor: 20.543

Review 8.  Novel therapeutic approaches for inclusion body myositis.

Authors:  Thomas E Lloyd
Journal:  Curr Opin Rheumatol       Date:  2010-11       Impact factor: 5.006

Review 9.  New insights into the benefits of exercise for muscle health in patients with idiopathic inflammatory myositis.

Authors:  Li Alemo Munters; Helene Alexanderson; Leslie J Crofford; Ingrid E Lundberg
Journal:  Curr Rheumatol Rep       Date:  2014-07       Impact factor: 4.592

10.  Klotho, FGF21 and FGF23: Novel Pathways to Musculoskeletal Health?

Authors:  B Bartali; R D Semba; A B Araujo
Journal:  J Frailty Aging       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.